Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    NIH, CDC Small Business Innovation for Medical Countermeasures

    By Global Biodefense StaffNovember 12, 2012
    Share
    Facebook LinkedIn Reddit Email

    An extended proposal deadline has been issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) for a Small Business Innovation Research (SBIR) contract solicitation.

    The agencies seek small businesses that possess the research and development expertise to conduct innovative research that will contribute toward meeting their program objectives.

    An abbreviated list of topics of interest includes: 

    National Institute of Allergy and Infectious Diseases (NIAID): Integrated Multiplex Medical Diagnostics Platforms for Infectious Diseases; Aerosolized Delivery of Anti-Tubercular Drugs; Development of Long-Acting Formulations of HIV Anti-Retrovirals; Improved Formulations for Approved First and Second line anti-Tuberculosis (TB) Drugs 

    National Center for Immunization and Respiratory Diseases (NCIRD): Development of an Inactivated Rotavirus Vaccine for Use in Global Immunization; Thermostable Dry Measles Vaccine Formulation for Sublingual Administration

    National Center for Emerging Zoonotic and Infectious Diseases (NCEZID): Development of Nanoparticle Dengue Diagnostic Tests; Development of Tests in a Standardized Kit Format for Diagnosis of Arboviral Infections in Resource-Limited, Primary Health Care Setting; Reducing Antimicrobial Resistance through Improved use of Laboratory Testing Information in Healthcare Facilities

    CDC Center for Global Health (CGH): Diagnostic Needs for Neglected Tropical Diseases (NTD) Programs; Rapid Screening Tests to Prevent Congenital Infections and Ensure Blood Safety; Development of Diagnostic Tests for Strongyloidiasis and Schistosomiasis 

    National Center for Advancing Translational Sciences (NCATS): Assay Development for High-Throughput Screening of Chemicals of Toxicological Concern; Visualizing Knowledge about Human Health and the Pathways of Translation; Biomarker Study for Creatine Transporter Defect Disorders; Automated Instrument to Clean Microtiter Plates 

    National Heart, Lung and Blood Institute (NHLBI): Improving Safety and Efficacy of Red Blood Cells for Transfusion; Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging

    National Cancer Institute (NCI): RNAi Cancer Therapeutics using Nanotechnology; Development of Human Tissue Culture Systems that Mimic the Tumor Microenvironment; Development of CTC Isolation Technologies Enabling Downstream Single Cell Molecular Analysis; Wound Healing Preparations Incorporating Nitric Oxide-Releasing Materials; Technology to Generate Anti-Peptide Capture Reagents for Affinity-Enriched Proteomic Studies; Chemically Defined Glycan Libraries for Reference Standards and Glycomics Research; Novel Imaging Agents to Expand the Clinical Toolkit; Innovative Radiation Sources for Advanced Radiotherapy Equipment

    Office of Public Health Preparedness and Response (OPHPR): Improved Methods for Collection, Preservation, and Transportation of Biological Specimens

    Further details are available under Solicitation Number: PHS2013-1.  The proposal response deadline was recently extended to December 3, 2012.

    Antimicrobials Biomarkers Dengue Multiplex Nanotech Neglected Tropical Diseases NIH Request for Proposals Thermostability Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNaval Medical Research Center Advancing Malaria Vaccines
    Next Article Open Access Initiative Helps Neglected Tropical Disease Drug Effort

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.